Molecular Basis for Synaptotagmin-1-Associated Neurodevelopmental Disorder

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Synaptotagmin-1 (syt1) is crucial for synchronized neurotransmitter release at neuronal synapses.
• Mutations in syt1 are linked to a severe, heterogeneous neurodevelopmental disorder.
• The pathogenic mechanisms and reasons for varied symptoms are not fully understood.

Purpose of the Study:

• To investigate the clinical, physiological, and biophysical effects of three syt1 mutations found in patients.
• To elucidate the molecular basis of syt1-associated neurodevelopmental disorder and phenotypic heterogeneity.
• To identify potential therapeutic strategies for this disorder.

Main Methods:

• Clinical assessment of patients with syt1 mutations.
• Electrophysiological recordings to study synaptic transmission in neurons expressing mutant syt1.
• Biophysical analysis to characterize the Ca2+ sensing properties of syt1 variants.
• Drug screening to identify compounds that can rescue the mutant phenotype.

Main Results:

• Neurons expressing mutant syt1 showed impaired synaptic transmission with dominant-negative effects.
• Biophysical studies revealed new insights into the cooperative action and functional specialization of syt1's Ca2+ sensing domains.
• A clinically approved K+ channel antagonist successfully rescued the dominant-negative heterozygous phenotype.

Conclusions:

• Established the molecular cause of syt1-associated neurodevelopmental disorder.
• Provided a basis for understanding the phenotypic heterogeneity observed in patients.
• Identified a potential therapeutic approach using a K+ channel antagonist for syt1-related disorders.